BFM 89.9
The Business Station
BFM 89.9
The Business Station
Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)
Recommended
47 mins
1 hr 27 mins
44 mins
Guest: Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center
Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.
Share:
Recent episodes
0
Latest stories
Johnson And Johnson- Rare Mutations Lung Cancer, and Targeted Therapies (PT2)
Guest: Dr Jennifer Leong, Consultant Clinical Oncologist, Sunway Medical Center
Genetic testing technology has improved our ability to identify mutations in lung cancer, which may lead to more aggressive and rapidly worsening disease. In tandem with genetic testing, new drugs are also being discovered every day to target these rare mutations. Consultant clinical oncologist Dr Jennifer Leong gives us a glimpse into how genetic testing and targeted therapy is the new future for lung cancer.
Share:
Recommended
Download app
60,000 other podcasts in your hand
Recent episodes
0
Latest Stories